DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidASDPFOfixed split S2paradoxical embolismdevice closure

Atrial septal defect and patent foramen ovale

Essential points for quick revision.

!
Escalate

Treat an acute stroke, systemic embolus, severe hypoxaemia or unstable atrial arrhythmia as an emergency; the presence of a PFO must not distract from reperfusion assessment or the search for another embolic source.

Synopsis

Distinguish haemodynamically important atrial septal defects from a usually incidental PFO and route closure decisions through specialist congenital or stroke services.

  • A secundum ASD is a true deficiency of atrial septal tissue; a PFO is a flap-like persistence of fetal communication and usually has no resting shunt.
  • A significant ASD produces right-atrial and right-ventricular volume loading, often with a wide fixed split second heart sound and pulmonary flow murmur.
  • A PFO is common and usually incidental; do not assume causality after stroke until alternative mechanisms have been excluded.

Key red flags

Shunt reversal

Cyanosis, clubbing and advanced pulmonary hypertension suggest right-to-left shunting and make routine closure dangerous.

Investigation priorities

01
12-lead ECGFirst step

Identify right-heart effects and atrial arrhythmia.

Management branches

FirstNew atrial-level shunt

Murmur, right-heart dilatation, unexplained hypoxaemia or incidental septal communication.

  1. Confirm anatomy and physiology with expert echocardiography rather than labelling every communication a PFO.
  2. Assess symptoms, oxygen saturation, rhythm, right-heart size, pulmonary pressure and associated anomalous veins or valves.
Open full textbook Answer 2 questionsCardiology check
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom